You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
As a systems developer,
I want the AnalyisAPI not doing database validations. Specifically, I would like the validation that all samples within a case should have the same AnalysisType done in this method to be implemented in the ordering,
So that we don't need to do database validations in the AnalysisAPI and the separation of concerns is respected.
Work impact
Answer the following questions:
Is there currently a workaround for this issue? If so, what is it?
No
How much time would be saved by implementing this feature on a weekly basis?
Nothing
How many users are affected by this issue?
System developers and Bioinfo developers interacting with the AnalysisAPI
Are customers affected by this issue?
No
Acceptance Criteria
There is a validation rule in the ordering service that verifies that all samples within a case have the same analysis type (i.e. TGS, WES, WGS or WTS) for all pipelines except MIP-DNA
The validation in the AnalysisAPI is removed as is no longer needed
...
Is this not a very weird check to have in the first place
So basically return "wts" if WTS application. If not, return "wgs" if WGS application, and all other applications get the "wes" analysis type? So all applications but WTS and WGS get WES as analysis type?
As a systems developer,
I want the AnalyisAPI not doing database validations. Specifically, I would like the validation that all samples within a case should have the same AnalysisType done in this method to be implemented in the ordering,
So that we don't need to do database validations in the AnalysisAPI and the separation of concerns is respected.
Work impact
Answer the following questions:
Acceptance Criteria
...
Notes
The text was updated successfully, but these errors were encountered: